Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to link the deaths of 25 children to COVID vaccines.
Trump health officials plan to include the claim in a presentation next week to a panel of advisors to the CDC that is considering new COVID vaccine recommendations, which can impact access to the shots and whether they’re free, according to the Washington Post.
Those deaths were seemingly gathered from information submitted to the government’s Vaccine Adverse Event Reporting System, according to the report.
VAERS contains unverified reports of side effects from vaccines, which can be submitted from anyone like patients and doctors to pharmacists or even someone who sees a story on social media.
The system is not meant to actually verify whether an immunization caused a death.
The presentation is not yet final, a person familiar with the matter told the Washington Post.
“FDA and CDC staff routinely analyze VAERS and other safety monitoring data, and those reviews are being shared publicly through the established ACIP process,” Andrew Nixon, communications director of the Health and Human Services Department, told The Post.
“Until that is shared publicly, any of this should be considered pure speculation.”
A spokesperson for Pfizer said real-world evidence, clinical and non-clinical data, and manufacturing data support the vaccine’s safety and effectiveness.
“The Pfizer-BioNTech COVID-19 vaccines have been administered to over a billion individuals, including adults, adolescents and children, generating robust data which demonstrate a favorable safety profile,” the spokesperson told The Post. --->READ MORE HERE
Do newborns need the hepatitis B vaccine to B healthy?
That’s slated to be deliberated Thursday at a meeting of the CDC’s Advisory Committee on Immunization Practices (ACIP). The influential vaccine advisory panel is expected to vote to recommend delaying a shot typically given at birth to age 4, NPR reported.
“There is going to likely be a discussion about hepatitis B vaccine, very specifically trying to dislodge the birth dose of hepatitis B vaccine and to push it later in life,” Demetre Daskalakis, the former director for the National Center for Immunization and Respiratory Diseases, told the outlet.
“Apparently this is a priority of the Secretary’s.”
Health Secretary Robert F. Kennedy Jr. has long questioned the safety of vaccines, including those for hepatitis B. He ousted all 17 ACIP members in June and appointed new ones ahead of this week’s key meeting, which will also review recommendations for COVID-19 vaccines.
Here’s a look at hepatitis B, a viral infection that’s the world’s leading cause of liver cancer, and the current vaccination recommendations.
How prevalent is hepatitis B?
Over 296 million people are living with chronic hepatitis B, making it the most common liver infection in the world.
In the US, as many as 2.4 million Americans may have a chronic case.
Acute hepatitis B becomes chronic when the patient’s immune system fails to clear the virus within six months of infection. --->READ MORE HEREFollow links below to relevant/related stories and resources:
COVID-19 no longer among the top 10 causes of death in the U.S.
What you need to know about Covid vaccines in the US this fall
USA TODAY: Coronavirus Updates
WSJ: Coronavirus Live Updates
YAHOO NEWS: Coronavirus Live Updates
NEW YORK POST: Coronavirus The Latest
If you like what you see, please "Like" and/or Follow us on FACEBOOK here, GETTR here, and TWITTER here.
No comments:
Post a Comment